-
AMA calls out payers on 15 years of 'parity failures,' seeks congressional support
The American Medical Association is calling on members of Congress to act on "repeated failures" of health insurers to comply with substance use and mental health parity regulations over the past 15 years. -
California universal healthcare bill dies before key vote
Lawmakers did not vote by its Jan. 31 deadline on a California Assembly bill that would establish universal healthcare in the state, killing the bill, according to the Los Angeles Times. -
346 House members reiterate bipartisan support for Medicare Advantage
Nearly 350 bipartisan members of the House of Representatives cosigned a letter to CMS stating their support for Medicare Advantage as the program continues to grow. -
AHIP, AHA comment on proposed standards for health plans in 2023
Both America's Health Insurance Plans and the American Hospital Association submitted comments to HHS and CMS on the agencies' 2023 benefit and payment parameters. -
Single-payer healthcare bill faces key decision in California
The California Assembly is poised to vote on a bill Jan. 31 that aims to create a single-payer healthcare system in the state — the bill's first major battle since a funding proposal for the program was introduced Jan. 6 — according to KTVU FOX 2. -
Patients trump HHS in Medicare nursing home coverage suit
A panel of three judges ruled against HHS in a move that will allow Medicare beneficiaries to appeal nursing home coverage decisions if they transitioned from inpatient care to outpatient observation, according to Kaiser Health News. -
Georgia sues HHS over removing Medicaid work requirement
The state of Georgia is suing HHS after the agency implemented changes that removed a requirement for Medicaid beneficiaries to work in order to be eligible for coverage, Bloomberg reported Jan. 21. -
Insurers paying up to 74% of costs for questionable COVID-19 treatment ivermectin
Health insurers are covering between 61 percent and 74 percent of the costs of ivermectin, a treatment for parasites in humans and animals, despite guidance from the FDA that it should not be used to treat COVID-19. -
Health New England expand at-home COVID-19 coverage
Health New England is expanding federally mandated coverage of at-home COVID-19 tests to include its Medicare Advantage members.
Page 17 of 50